CD274 and neoplasm: Additionally, to determine whether combination therapy with ATO and an anti-PD-L1 antibody induces a protective memory immune response, another set of tumors was rechallenged in mice whose tumors regressed after combination therapy in the EMT6 syngeneic tumor model.